Citigroup Inc Karuna Therapeutics, Inc. Call Options Transaction History

Citigroup Inc

  • $150 Billion
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$161.01 - $317.85 $627,939 - $1.24 Million
3,900 Added 24.22%
20,000 $6.33 Million
Q3 2023

Nov 09, 2023
SELL
$164.66 - $218.08 $642,174 - $850,512
-3,900 Reduced 19.5%
16,100 $2.72 Million
Q2 2023

Aug 10, 2023
BUY
$176.32 - $240.22 $3.53 Million - $4.8 Million
20,000 New
20,000 $4.34 Million

Others Institutions Holding KRTX

# of Institutions
13
Shares Held
333K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email